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Over the past three decades, scientists have realized that stem cells will play a central 
role in future therapies. These cells have key functions in tissue homeostasis and upon 
injury can replenish injured tissue. Aberrant activation of stem cells leads to disease such 
as cancer and degenerative diseases. However, in order to bring stem cells to the clinic, a 
profound understanding of the molecular regulation of these cells is a prerequisite. Here, 
in this special issue, we present a series of reviews summarizing recent advances in 
molecular mechanisms of stem cell pluripotency and cell fate specification. 
Pluripotency is a transient feature of cells residing in the inner cell mass of a developing 
blastocyst and is defined as the ability of a cell to contribute to all germ layers of the 
embryo. This plastic state can be captured in vitro and conserved as Embryonic Stem 
Cells (ESCs) under suitable culture conditions. These cells remain pluripotent and are 
able to self-renew indefinitely in vitro [1]. Mouse ESCs were first derived from blastocysts 
in the early 1980s [2, 3], whilst in 1998 the Thomson laboratory derived human ESCs for 
the first time [4]. More recently, Yamanaka and colleagues achieved THE breakthrough in 
pluripotency research when they reported reprogramming of somatic mouse [5] and 
human [6] cells to an ESC-like state. And so the term induced pluripotent stem cells 
(iPSC) was coined.  
Capturing pluripotent stem cells in the laboratory has allowed researchers to 
delineate signaling cues and molecular mechanisms responsible for stem cell 
maintenance and cell fate specification. In parallel, a major research effort was initiated to 
unveil the enormous potential of pluripotent cells for regenerative/personalized medicine. 
In recent years, seminal studies defined and refined conditions for deriving clinically 
relevant cell populations from pluripotent cells, including cardiomyocytes, cells of the 
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peripheral and central nervous system, hepatocytes and pancreatic -cells (for a review 
see: [7]). The advent of human ESCs and iPSCs thereby opened unprecedented 
opportunities for future therapeutics, regenerative medicine, drug screening and modeling 
of human diseases. 
 
In this special issue of the Journal of Molecular Biology, we focus on research which 
elucidates fundamental biological mechanisms using stem cells and their derivatives as 
model systems. So far, pluripotent stem cells provide us with a model to fill the void in our 
knowledge of early human development. Furthermore, stem cells give us the great 
opportunity to study basic molecular mechanisms such as cell signaling, epigenetics, 
RNA interference and transcriptional regulation in an undisturbed genome, in contrast to 
cancer cell lines.  
 
In the first review of this special issue, Jörg Betschinger [8] gives an overview on an 
emerging question in stem cell biology: How is pluripotency network dissolution controlled 
to enable cells to differentiate efficiently towards the three embryonic germ layers. This 
has implications far beyond simple development, as correct resolution of the pluripotent 
state towards differentiation is crucial for cells to be safely applied in therapeutics. Linking 
the molecular framework described over recent years to cell fate specification in the early 
murine embryo, he raises important questions to be addressed in future studies.   
 
Reviews by the Navarro, Baubec and Wutz laboratories shift the focus towards epigenetic 
regulation of gene expression using pluripotent stem cells as a model system [9, 10] Wutz: 
not yet available). The Navarro lab proposes a novel concept that ESCs present an 
“epigenetic paradox”: They are stably captured in a self-renewing state which maintains 
their identity. However, this state is not entirely dependent on classical epigenetic 
mechanisms but rather is stabilized by transcription factors and a particular chromatin 
state dependent on extrinsic signalling [10]. In a similar vein, reviews by the Baubec and 
Wutz laboratories provide insights into the mechanisms and dynamics of DNA methylation 
and facultative heterochromatin formation using mESCs as model system. These 
processes are essential for correct cell fate specification and mis-regulation has been 
implicated in cancer.  
 
The last set of reviews discusses recent insights into emerging molecular mechanisms of 
post-transcriptional/translational regulation of pluripotency. The Findlay laboratory provides 
an overview of kinase signaling networks, many of which have been studied in disease 
systems rather than in pluripotency (Ref not on Pubmed yet). Interestingly, they focus on 
novel kinase cascades and those implicated in the cell cycle, DNA damage response, 
nutrition sensing, metabolism and cell stresses and thereby provide a new perspective on 
these core cellular processes in the context of pluripotency. RNA interference (RNAi) is 
another crucial post-transcriptional mechanism to fine-tune gene expression programs. 
small RNAs together with their effector proteins have been shown to play essential roles in 
pluripotency and cell fate specification. The Ciaudo group contributes a review to this issue 
summarizing recent advances of RNAi in stem cell biology focusing on the underlying 
mechanisms and non-canonical functions of RNAi effector proteins [11]. 
 
Last but not least, an original article by the Chambers laboratory provides us with an 
outstanding example of how stem cells can be used as “model organism” to study the 
molecular and biochemical functions of proteins [12]. They investigate the function of a key 
tryptophan repeat within the Nanog pluripotency transcription factor. They show that these 
residues are essential pluripotency and self-renewal of mESCs, and provide mechanistic 
insights into how the tryptophan repeat contributes to Nanog homo- (and potentially 
hetero-) dimerization and thereby to transcriptional activity.  
 
To date, stem cell research centered mainly on developing protocols to produce specific 
cell types to model diseases and to provide cells for clinical application in tissue 
regeneration and cell replacement. In this special issue, we provide a new perspective on 
stem cell biology; that these cells can be used as model system to study the molecular 
mechanisms of fundamental biology. We envision that extending ESC research to new 
fields by applying newly developed methodologies (e.g. CRISPR/Cas9 genome editing, 
proteomics and genomics), then stem cells can become the yeast of the 21st century. In 
the long term, progress in understanding basic molecular mechanisms will potentially 
translate into medical applications. 
 
We would like to take the opportunity to thank all the authors and reviewers for their efforts 
and hope that you will enjoy reading the articles in this special issue as much as we 
enjoyed editing them! 
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